Jasper Therapeutics JSPR Cash Flow Statement (2020-2025)

NASDAQ JSPR
$0.69 -0.06 (-8.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
5.50M-3.57M-10.08M-11.93M-17.74M-11.97M-13.19M-14.24M-13.13M-17.58M-21.29M-16.78M-14.39M-15.02M-22.47M-24.64M-21.32M-28.89M-18.88M-16.00M
Share-based Compensation (Quarter)
0.33M0.29M0.20M0.23M0.78M1.06M4.09M-0.09M1.27M0.00M1.40M0.30M1.17M1.48M2.00M1.97M15.00M1.82M10.70M1.66M
Gains from Investment Securities (Quarter)
-0.05M-6.05M-0.84M-0.15M-0.15M0.57M-2.10M-6.43M
Asset Writedowns and Impairment (Quarter)
0.11M0.11M0.12M0.12M0.12M0.13M0.19M0.32M0.33M0.33M
Cash from Operations (Quarter)
-6.20M-5.79M-7.11M-14.58M-14.21M-9.36M-9.63M-12.70M-10.30M-13.30M-11.99M-16.51M-15.70M-11.70M-14.07M-21.13M-22.84M-15.46M-16.99M-21.91M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.10M0.09M-0.03M0.04M0.06M0.10M0.09M0.09M0.10M0.10M
Depreciation & Amortization (CF) (Quarter)
0.02M0.10M0.10M0.19M0.20M0.20M0.30M0.30M0.27M0.30M0.30M0.28M0.29M0.30M0.50M0.27M0.28M0.30M0.20M0.33M
Change in Working Capital
Change in Receivables (Quarter)
-0.66M
Change in Account Payables (Quarter)
0.08M1.55M-0.41M1.72M-2.45M1.48M0.17M-1.35M2.08M-2.27M1.68M0.89M-1.76M0.46M0.22M0.96M-1.04M5.05M1.13M-2.95M
Change in Accured Expenses (Quarter)
0.00M1.13M1.94M-2.11M0.39M-0.28M-0.24M0.97M-1.32M3.32M1.24M-0.42M-1.73M0.55M2.24M1.82M-2.62M3.01M-0.70M-4.07M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-0.11M-0.11M-0.16M2.11M-0.02M-0.40M-0.22M-0.23M-0.23M-0.24M-0.25M-0.26M-0.32M-0.43M-0.45M-0.47M
Investing Activities
Capital Expenditures (Quarter)
0.96M-0.29M1.05M0.71M0.03M-0.10M-0.03M0.68M0.03M0.01M-0.39M0.61M0.03M-0.20M0.64M0.10M-0.29M0.29M
Sales of Property, Plant and Equipment (Quarter)
0.00M0.01M
Cash from Investing Activities (Quarter)
-0.96M-0.29M-0.47M-0.71M-0.03M-0.24M-0.22M-0.08M-0.03M-0.01M-0.23M-0.03M-0.16M-0.27M-0.08M0.00M0.00M
Financing Activities
Other financing activities (Quarter)
0.00M0.07M0.13M0.03M0.01M0.01M0.00M0.00M0.03M0.32M0.04M0.15M-0.11M0.28M0.02M
Debt Issuance and Repayment
Short-Term Debt issuances (Quarter)
1.13M-0.06M
Change in Capital Stock
Shares Issued (Quarter)
1.43M0.05M5.89M5.54M1.30M0.05M0.20M0.50M1.20M1.04M0.08M0.02M1.56M0.05M0.50M0.48M0.72M0.42M
Net Equity Issued and Repurchased (Quarter)
10.75M101.48M47.20M0.51M
Misc.
Cash from Financing Activities (Quarter)
10.75M-0.60M91.73M-0.91M0.01M0.01M0.00M0.03M101.51M-0.30M0.04M-0.27M47.35M0.18M0.01M0.34M28.39M-0.34M
Change in Cash (Quarter)
3.60M-6.68M84.15M-16.20M-14.23M-9.59M-9.86M-12.70M91.15M-13.59M-11.95M-16.98M31.59M-11.66M-14.32M-20.86M-22.84M-9.29M11.39M-22.21M
Free Cash Flow (Quarter)
-7.16M-5.50M-8.16M-15.29M-14.24M-9.26M-9.60M-13.38M-10.33M-13.31M-11.60M-17.13M-15.72M-11.49M-14.70M-21.23M-22.55M-15.75M-16.99M-21.91M
Net Cash Flow (Quarter)
3.60M-6.68M84.15M-16.20M-14.23M-9.59M-9.85M-12.75M91.19M-13.62M-11.95M-17.01M31.62M-11.68M-14.33M-20.86M-22.84M-15.46M11.39M-22.25M